Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CapStar Financial | CSTR | Apr 19, 2024 | 20.10 | 0.00 |
Captivision | CAPT | Apr 19, 2024 | 4.64 | -5.69 |
Cara Therapeutics | CARA | Apr 19, 2024 | 0.66 | -4.20 |
Caravelle International Group | CACO | Apr 19, 2024 | 1.03 | -9.65 |
Carbon Revolution | CREV | Apr 19, 2024 | 14.21 | +3.72 |
Cardiff Oncology | CRDF | Apr 19, 2024 | 4.35 | -0.46 |
Cardinal Health | CAH | Apr 19, 2024 | 108.19 | +2.07 |
Cardio Diagnostics | CDIO | Apr 19, 2024 | 0.87 | -20.18 |
Cardiol Therapeutics | CRDL | Apr 19, 2024 | 1.77 | +5.99 |
Cardlytics | CDLX | Apr 19, 2024 | 12.22 | +2.35 |
CareCloud | CCLD | Apr 19, 2024 | 1.14 | -0.87 |
CareCloud A Pref | CCLDP | Apr 19, 2024 | 5.70 | -0.35 |
CareCloud B Pref | CCLDO | Apr 19, 2024 | 6.12 | +1.49 |
CareDx | CDNA | Apr 19, 2024 | 8.31 | +2.97 |
CareMax A | CMAX | Apr 19, 2024 | 2.57 | +7.08 |
CareTrust REIT | CTRE | Apr 19, 2024 | 23.69 | -0.21 |
CARGO Therapeutics | CRGX | Apr 19, 2024 | 19.19 | +0.47 |
CarGurus A | CARG | Apr 19, 2024 | 22.20 | +3.06 |
Caribou Biosciences | CRBU | Apr 19, 2024 | 3.85 | -1.53 |
Carisma Therapeutics | CARM | Apr 19, 2024 | 1.63 | -4.68 |
Carlisle Companies | CSL | Apr 19, 2024 | 367.41 | 0.00 |
Carlyle Credit Income Fund | CCIF | Apr 19, 2024 | 7.75 | -0.13 |
Carlyle Credit Income Fund | CCIA | Apr 19, 2024 | 25.50 | +0.53 |
Carlyle Secured Lending | CGBD | Apr 19, 2024 | 16.70 | -0.12 |
CarMax | KMX | Apr 19, 2024 | 68.34 | +0.63 |
Carmell | CTCX | Apr 19, 2024 | 1.98 | -12.03 |
Carnival | CCL | Apr 19, 2024 | 14.12 | -0.42 |
Carnival ADR | CUK | Apr 19, 2024 | 12.73 | -0.55 |
CarParts.com | PRTS | Apr 19, 2024 | 1.28 | -0.78 |
Carpenter Technology | CRS | Apr 19, 2024 | 78.04 | -1.69 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.